UNSPSC 51143501: Carbidopa/entacapone/levodopa
Commodity
Code facts
- Part of
-
-
51000000
-
51140000
- 51143500
-
51140000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51143501
Definition
This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN500. This VA Drug Class (CN500) classifies this compound as belonging to the group ANTIPARKINSON AGENTS.
About UNSPSC 51143501
UNSPSC 51143501 Carbidopa/entacapone/levodopa is a Commodity code that nominally refers to a specific Parkinson's disease medication combination, but recent state and local opportunities tagged under this code show minimal alignment with that narrow pharmaceutical scope. The code shows little relevant recent activity; the three most recently posted opportunities under this identifier involve naloxone and drug deactivation systems, a Texas HHS direct-to-manufacturer prescription program RFI, and a multistate cooperative purchasing agreement for generic pharmaceuticals and OTC products — none of which are carbidopa/entacapone/levodopa formulations. This mismatch suggests either systematic miscoding in the source data or that the code is being used as a catch-all for broader pharmaceutical procurement when more specific commodity codes do not apply.
The recent opportunities that do appear show procurement by state health agencies and county government bodies across Texas, Minnesota, and Florida. Seminole County, Florida issued an IFB (IFB60459723LAS) on June 30, 2026 for naloxone and drug deactivation systems with a response deadline of July 26, 2023; the Minnesota Department of Administration's Office of State Procurement, administering the MMCAP cooperative purchasing vehicle, issued an RFP (S1070000015802) on January 20, 2026 for generic multi-source pharmaceuticals and OTC products with a due date of March 26, 2026; and the Texas Health and Human Services Commission issued an RFI (HHS0017013) on April 3, 2026 to gather market intelligence on direct-to-manufacturer prescription programs. Given the absence of carbidopa/entacapone/levodopa in any identified solicitation, this code warrants investigation before committing resources to pursuit under the stated commodity title.
Quick answers
What is UNSPSC 51143501?
UNSPSC 51143501 is Carbidopa/
Which NIGP codes match UNSPSC 51143501?
UNSPSC 51143501 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).
On GovTribe
See everything under UNSPSC 51143501
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code